Vitamin D receptor ligands, adenomatous
✍
Jan B. Egan; Patricia A. Thompson; Milen V. Vitanov; Leonid Bartik; Elizabeth T.
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
English
⚖ 409 KB
## Abstract The activity of β‐catenin, commonly dysregulated in human colon cancers, is inhibited by the vitamin D receptor (VDR), and this mechanism is postulated to explain the putative anti‐cancer activity of vitamin D metabolites in the colon. We investigated the effect of a common __Fok__I res